Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta

被引：0
|
作者：
Zoulim, Fabien [1 ]
Asselah, Tarik [2 ]
Chulanov, Vladimir [3 ]
Streinu-Cercel, Adrian [4 ,5 ]
Gherlan, George Sebastian [5 ,6 ]
Bogomolov, Pavel [7 ]
Stepanova, Tatyana [8 ]
Morozov, Viacheslav [9 ]
Sagalova, Olga [10 ]
Mercier, Renee-Claude [11 ]
Ye, Lei [11 ]
Manuilov, Dmitry [11 ]
Lau, Audrey H. [11 ]
Chee, Grace M. [11 ]
Da, Ben L. [11 ]
Bourliere, Marc [12 ]
Wedemeyer, Heiner [13 ]
Lampertico, Pietro [14 ,15 ]
机构：
[1] Hosp Croix Rousse, Lyon, France
[2] Univ Paris, Hop Beaujon, APHP, INSERM, Clichy, France
[3] Sechenov Univ, Moscow, Russia
[4] Matei Bals Natl Inst Infect Dis, Bucharest, Romania
[5] Carol Davila Univ Med & Pharm, Bucharest, Romania
[6] Victor Babes Fdn, Bucharest, Romania
[7] MF Vladimirsky Moscow Reg Res & Clin Inst, Moscow, Russia
[8] LLC Clin Modern Med, Moscow, Russia
[9] LLC Med Co Hepatol, Samara, Russia
[10] South Ural State Med Univ, Chelyabinsk, Russia
[11] Gilead Sci Inc, Foster City, CA USA
[12] Hop St Joseph, Marseille, France
[13] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[14] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[15] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-395
引用
收藏
页码：S796 / S796
页数：1
相关论文
共 50 条
  • [31] Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patients
    Korkmaz, Pinar
    Usluer, Gaye
    Ozgunes, Ilhan
    Kartal, Elif Doyuk
    Erben, Nurettin
    Alpat, Saygin Nayman
    NORTHERN CLINICS OF ISTANBUL, 2014, 1 (01) : 26 - 32
  • [32] Pegylated interferon alpha-2a (Pegasys) versus pegylated interferon alpha-2b (Pegintron) in the treatment of chronic hepatitis C infection
    Anees, MR
    Reddymasu, S
    Bejjanki, HR
    Caldito, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S142 - S142
  • [33] Myocardial ischemia due to pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B
    Qu, Caihong
    Zheng, Zhenda
    Li, Xiaoyan
    Zhu, Jieming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C275 - C275
  • [34] HEPATITIS B SURFACE ANTIGEN ( HBSAG) RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS DELTA RECEIVING BULEVIRTIDE WITH OR WITHOUT PEGYLATED INTERFERON ALFA-2A IN MYR204
    Liu, Yang
    Li, Jiani
    Chang, Silvia
    Hu, Yu
    Xu, Simin
    Martin, Ross
    Manuilov, Dmitry
    Mercier, Renee-Claude
    Lau, Audrey
    Asselah, Tarik
    Zoulim, Fabien
    Chulanov, Vladimir
    Mo, Hongmei
    Maiorova, Evguenia
    HEPATOLOGY, 2024, 80 : S126 - S127
  • [35] TREATMENT OF CHRONIC DELTA HEPATITIS WITH ALPHA-2 RECOMBINANT INTERFERON (IFN)
    ROSINA, F
    SARACCO, G
    ACTIS, GC
    BRUNETTO, MR
    MARAN, E
    PINTUS, C
    DIANZANI, F
    VERME, G
    RIZZETTO, M
    BONINO, F
    GASTROENTEROLOGY, 1986, 90 (05) : 1762 - 1762
  • [36] TREATMENT OF CHRONIC DELTA-HEPATITIS WITH HIGH AND LOW-DOSES OF INTERFERON ALPHA-2A - A RANDOMIZED CONTROLLED TRIAL
    FARCI, P
    MANDAS, A
    LAI, ME
    FARCI, AMG
    FAA, G
    CARUSO, L
    TRISCHITTA, C
    SCACCABAROZZI, S
    RYFF, JC
    BALESTRIERI, A
    HEPATOLOGY, 1990, 12 (04) : 869 - 869
  • [37] Superficial venous thrombophlebitis associated with pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B
    Kalafateli, Maria
    Triantos, Christos
    Kakkos, Stavros K.
    Mougiou, Athina
    Labropoulou-Karatza, Chryssoula
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (03) : 328 - 329
  • [38] Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
    Jose Urquijo, Juan
    Diago, Moises
    Boadas, Jaume
    Planas, Ramon
    Sola, Ricard
    Angel del Olmo, Juan
    Crespo, Javier
    Carlos Erdozain, Jose
    Dolores Anton, Maria
    Arocena, Carlos
    Suarez, Dolores
    Gine, Josep
    Barrera, Josep M.
    Garcia-Samaniego, Javier
    Perez, Ricardo
    Dalmau, Blai
    Montoro, Miguel
    ANNALS OF HEPATOLOGY, 2013, 12 (01) : 30 - 35
  • [39] No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
    Hollnberger, Julius
    Liu, Yang
    Xu, Simin
    Chang, Silvia
    Martin, Ross
    Manhas, Savrina
    Aeschbacher, Thomas
    Han, Bin
    Yazdi, Tahmineh
    May, Lindsey
    Han, Dong
    Shornikov, Alex
    Flaherty, John
    Manuilov, Dmitry
    Suri, Vithika
    Asselah, Tarik
    Lampertico, Pietro
    Wedemeyer, Heiner
    Aleman, Soo
    Richards, Christopher
    Mateo, Roberto
    Maiorova, Evguenia
    Cihlar, Tomas
    Mo, Hongmei
    Urban, Stephan
    JOURNAL OF HEPATOLOGY, 2023, 79 (03) : 657 - 665
  • [40] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
12345